Optinose ( (OPTN) ) has released its Q3 earnings. Here is a breakdown of the information Optinose presented to its investors. Optinose is a ...

Amsellem covers the Healthcare sector, focusing on stocks such as Alkermes, Supernus Pharmaceuticals, and Corcept Therapeutics. Optinose has an analyst consensus of Moderate Buy, with a price target ...

SAN RAFAEL, Calif., Nov. 6, 2024 /PRNewswire/ -- BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) today announced that management will present at three upcoming investor conferences. BioMarin ...

South Korea’s reputable yet increasingly taxed healthcare industry depends on a robust pharmaceutical sector. As domestic and international demand has increased, the country has further proven ...

Hikma Pharmaceuticals Usa Inc was founded in 2011 and operates in Eatontown, United States. The company engages in the sector 'Pharmaceuticals, Medicinal Chemical & Botanical Products' (ISIC ...

OptiNose, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of products for patients treated by ear, nose, throat, and allergy specialists in the United ...

Publication describes the structure of phage Pa193, a top candidate for inclusion into Armata's multi-phage anti-Pseudomonas clinical products LOS ANGELES, Oct. 30, 2024 /PRNewswire/ -- Armata ...

GLP-1 receptor agonists and SGLT2 inhibitors, two classes of medications most commonly prescribed to treat Type 2 diabetes or weight loss, may reduce the risk of heart attack, second strokes and ...

OptiNose , Inc., a pharmaceutical company, has received notice from Nasdaq that its stock price has not met the minimum bid requirement for continued listing on the Nasdaq Global Market.

YARDLEY, Pa., Oct. 16, 2024 (GLOBE NEWSWIRE) -- OptiNose, Inc. (NASDAQ:OPTN), a pharmaceutical company focused on patients treated by ear, nose and throat (ENT) and allergy specialists, today ...

OptiNose , Inc., a pharmaceutical company, has received notice from Nasdaq that its stock price has not met the minimum bid requirement for continued listing on the Nasdaq Global Market. The company's ...

OptiNose OPTN is gearing up to announce its quarterly earnings on Tuesday, 2024-11-12. Here's a quick overview of what investors should know before the release. Analysts are estimating that ...